MAIA Biotechnology, Inc.MAIANYSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank90
3Y CAGR+114.6%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+114.6%/yr
Quarterly compound
Percentile
P90
Near historical high
vs 3Y Ago
9.9x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 104.36% |
| Q2 2025 | -2.71% |
| Q1 2025 | 7.69% |
| Q4 2024 | 11.32% |
| Q3 2024 | 29.96% |
| Q2 2024 | -11.57% |
| Q1 2024 | -37.57% |
| Q4 2023 | 43.00% |
| Q3 2023 | 0.01% |
| Q2 2023 | 18.37% |
| Q1 2023 | 5.59% |
| Q4 2022 | -11.24% |
| Q3 2022 | 10.55% |
| Q2 2022 | 3.49% |
| Q1 2022 | 39.83% |
| Q4 2021 | 35.40% |
| Q3 2021 | 67.97% |
| Q2 2021 | 145.09% |
| Q1 2021 | -53.32% |
| Q4 2020 | 274.25% |
| Q3 2020 | 0.00% |